Viking Therapeutics Inc VKTXW Valuation Ratios and Share Stats

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Viking Therapeutics Inc (VKTXW)
Viking Therapeutics Inc (VKTXW) Financials

Viking Therapeutics Inc (VKTXW)

4.60

0.00

(0.00%)

Closed May 17 4:00PM

Delayed by 15 minutes

0.00

0.00

(0.00%)

After Hours: -

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Return on Assets (%)	-98.295	-112.273	-13.601	-8.79	-14.607	-23.542	-36.323	-31.99
Return on Equity (%)	-175.716	-191.352	-14.179	-8.969	-15.148	-24.647	-39.669	-34.794
Return on Invested Capital (%)	-135.152	-184.447	-16.836	-11.379	-16.37	-24.967	-40.547	-40.859
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	0.386	0.376	4.15	3.827	3.337	2.58	1.911	3.483
Earnings Per Share	-0.707	-0.575	-0.308	-0.356	-0.539	-0.703	-0.905	-0.859
Cash Per Share	0.148	0.251	0.345	0.116	0.398	0.337	0.482	0.555
Working Capital Per Share	0.36	0.368	4.148	3.821	3.332	2.578	1.908	3.48
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	-0.707	-0.575	-0.308	-0.356	-0.539	-0.703	-0.905	-0.859
EBITDA Per Share	-0.707	-0.575	-0.308	-0.356	-0.539	-0.703	-0.905	-0.859
Free Cash Flow Per Share	-0.707	-0.575	-0.308	-0.356	-0.539	-0.703	-0.905	-0.859

Liquidity Ratios

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	2.158	2.524	66.403	41.833	21.115	23.984	7.611	19.191
Quick Ratio	2.03	2.377	66.268	40.673	20.479	23.024	7.085	18.922
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	20.82M	35.82M	71.74M	72.41M	73.22M	78.25M	76.06M	N/A

Key Stats and Ratios

Year End December 30 2023	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Shares Outstanding	74.5M	74.5M	76.06M	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	9.551	N/A	N/A	N/A	29.485
Quick Ratio	N/A	N/A	N/A	8.669	N/A	N/A	N/A	29.382
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	6.7B
Price to Earnings Ratio	-78.02
Price to Sales Ratio	0
Price to Cash Ratio	120.72
Price to Book Ratio	19.24
Dividend Yield	-

Share Statistics

Shares Outstanding	100.03M
Average Volume (1 week)	0
Average Volume (1 Month)	0
52 Week Change	-
52 Week High	-
52 Week Low	-

More Ratios Coming Soon!

Viking Therapeutics

BNP Paribas Issuance

NAVCO Pharmaceuticals

Innovator Growth Acceler...

BNP Paribas Issuance

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions